102 related articles for article (PubMed ID: 38717936)
1. KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression.
Guo W; Wang T; Huai Q; Guo L; Wang X; He J
Thorac Cancer; 2024 May; ():. PubMed ID: 38717936
[TBL] [Abstract][Full Text] [Related]
2. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
3. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma.
Guo L; Huai Q; Zhou B; Ying J; Guo W
Cancer Innov; 2022 Dec; 1(4):328-343. PubMed ID: 38089085
[TBL] [Abstract][Full Text] [Related]
5. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
6. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
7. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m
Lin X; Ye R; Li Z; Zhang B; Huang Y; Du J; Wang B; Meng H; Xian H; Yang X; Zhang X; Zhong Y; Huang Z
Drug Resist Updat; 2023 Jan; 66():100908. PubMed ID: 36493511
[TBL] [Abstract][Full Text] [Related]
8. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
Chen X; Lu T; Cai Y; Han Y; Ding M; Chu Y; Zhou X; Wang X
Cell Mol Biol Lett; 2023 Apr; 28(1):32. PubMed ID: 37076815
[TBL] [Abstract][Full Text] [Related]
9. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract][Full Text] [Related]
10. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Cheng X; Li M; Rao X; Zhang W; Li X; Wang L; Huang G
Onco Targets Ther; 2019; 12():3421-3428. PubMed ID: 31118692
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing.
Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y
Front Oncol; 2022; 12():791332. PubMed ID: 35903698
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.
Gan L; Zhao S; Gao Y; Qi Y; Su M; Wang A; Cai H
Biol Direct; 2023 Oct; 18(1):64. PubMed ID: 37807062
[TBL] [Abstract][Full Text] [Related]
13. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner.
Ma L; Lin Y; Sun SW; Xu J; Yu T; Chen WL; Zhang LH; Guo YC; Wang YW; Chen T; Wei JF; Zhu LJ
Oncogene; 2022 Jan; 41(5):692-703. PubMed ID: 34819634
[TBL] [Abstract][Full Text] [Related]
14. KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN.
Meng Y; Yang W; Li J; Chai W
Heliyon; 2023 Nov; 9(11):e22084. PubMed ID: 38058614
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
Teng Y; Zhao X; Xi Y; Fu N
Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
[TBL] [Abstract][Full Text] [Related]
16. SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer.
Zhang X; Dai XY; Qian JY; Xu F; Wang ZW; Xia T; Zhou XJ; Li XX; Shi L; Wei JF; Ding Q
Mol Ther Nucleic Acids; 2022 Mar; 27():133-146. PubMed ID: 34976433
[TBL] [Abstract][Full Text] [Related]
17. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP; Huang XY
Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
[TBL] [Abstract][Full Text] [Related]
19. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
20. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
Chen X; Fan R
J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
